- Analysis of relevant genetic variants for the assessment of Alzheimer’s disease risk through analysis of apolipoprotein E (APOE) types.
- Adaptation of a personalized prevention program to delay the development of the disease for years. Lifestyle modifications, such as changes in physical activity, smoking, and mental stimulation.
- Personalised diet and recommendation for specific nutrient intake for reducing the risk.
- Detection and evaluation of the effect of various drugs associated with Alzheimer.